Delivery Order SPE2DB22D3301-SPE2DB26FX3KP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) on October 16, 2025, with a ceiling value of $6,927.78 and an ultimate completion date of October 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitively awarded contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which is the headquarters location of...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 tablets) on September 8, 2025, with an ultimate completion date of September 9, 2025. This contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $6,948.25 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Citalopram HBr 20 mg tablets (500 count). This competitive award utilizes firm fixed pricing with a completion date of September 8, 2025, and represents a non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Citalopram HBR 20 mg tablets (500 count) with a ceiling value of $16,986.60. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a competitively awarded, non-set-aside contract executed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $17,210.57 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Citalopram HBR 20 mg tablets in quantities of 500 units. This firm fixed-price delivery order carries a ceiling value of $34,632.46 and is scheduled for completion by September 19, 2025. The contract was awarded competitively without set-aside designation to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $10,959.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Citalopram HBr 20 mg tablets (500 count) valued at $1,582.47. This firm fixed-price delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units, with a ceiling value of $6,023.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by September 3, 2025, and will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) with a ceiling value of $1,733.43. This competitive award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The contract is performed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3KPDelivery Order
The Defense Logistics Agency awarded a $27,768.05 delivery order to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with critical medical commodities including brand-name and generic drugs, vaccines, and specialty medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 10/16/25 |